Texas Health Presbyterian Hospital Rockwall | |
3150 Horizon Road, Rockwall, Texas 75032 | |
(469) 698-1000 | |
Name | Texas Health Presbyterian Hospital Rockwall |
---|---|
Type | Acute Care Hospital |
Location | 3150 Horizon Road, Rockwall, Texas |
Ownership | Proprietary |
Emergency Services | Yes |
Medicare ID (CCN) | 670044 |
NPI Number | 1619123908 |
Organization Name | ROCKWALL REGIONAL HOSPITAL, LLC |
Doing Business As | TEXAS HEALTH PRESBYTERIAN HOSPITAL ROCKWALL |
Address | 3150 Horizon Rd, Rockwall, TX 75032 |
Hospital Type | General Acute Care Hospital |
Phone Number | 469-698-1000 |
News Archive
Dezima Pharma ('Dezima'), the biotechnology company developing innovative drugs in the field of dyslipidemia, announced today the in-licensing of a cholesteryl ester transfer protein (CETP) inhibitor DEZ-001 (formerly TA-8995) from Mitsubishi Tanabe Pharma Corporation (MTPC). Terms of the deal were not disclosed.
"As the war on AIDS heads into its fourth decade, the need for funds is spiralling relentlessly higher, prompting a quest for new resources from consumer levies to contributions from developing giants," Agence France-Presse/France 24 reports (5/30).
A University of Manchester professor and his wife have had their own DNA analysed for compatibility as part of the research for a new book out on 1 October in the US and next week in the UK.
Halozyme Therapeutics, Inc. today announced that AbbVie has dosed the first subject in a clinical trial evaluating the safety and pharmacokinetics of adalimumab with Halozyme's proprietary ENHANZE technology.
› Verified 4 days ago
NPI Number | 1629138029 |
Organization Name | ROCKWALL REGIONAL HOSPITAL, LLC |
Doing Business As | TEXAS HEALTH PRESBYTERIAN HOSPITAL ROCKWALL |
Address | 3150 Horizon Rd, Rockwall, TX 75032 |
Hospital Type | General Acute Care Hospital |
Phone Number | 469-698-1000 |
News Archive
Dezima Pharma ('Dezima'), the biotechnology company developing innovative drugs in the field of dyslipidemia, announced today the in-licensing of a cholesteryl ester transfer protein (CETP) inhibitor DEZ-001 (formerly TA-8995) from Mitsubishi Tanabe Pharma Corporation (MTPC). Terms of the deal were not disclosed.
"As the war on AIDS heads into its fourth decade, the need for funds is spiralling relentlessly higher, prompting a quest for new resources from consumer levies to contributions from developing giants," Agence France-Presse/France 24 reports (5/30).
A University of Manchester professor and his wife have had their own DNA analysed for compatibility as part of the research for a new book out on 1 October in the US and next week in the UK.
Halozyme Therapeutics, Inc. today announced that AbbVie has dosed the first subject in a clinical trial evaluating the safety and pharmacokinetics of adalimumab with Halozyme's proprietary ENHANZE technology.
› Verified 4 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Dezima Pharma ('Dezima'), the biotechnology company developing innovative drugs in the field of dyslipidemia, announced today the in-licensing of a cholesteryl ester transfer protein (CETP) inhibitor DEZ-001 (formerly TA-8995) from Mitsubishi Tanabe Pharma Corporation (MTPC). Terms of the deal were not disclosed.
"As the war on AIDS heads into its fourth decade, the need for funds is spiralling relentlessly higher, prompting a quest for new resources from consumer levies to contributions from developing giants," Agence France-Presse/France 24 reports (5/30).
A University of Manchester professor and his wife have had their own DNA analysed for compatibility as part of the research for a new book out on 1 October in the US and next week in the UK.
Halozyme Therapeutics, Inc. today announced that AbbVie has dosed the first subject in a clinical trial evaluating the safety and pharmacokinetics of adalimumab with Halozyme's proprietary ENHANZE technology.
› Verified 4 days ago
Texas Health Presbyterian Hospital Rockwall Acute Care Hospital Location: 3150 Horizon Road, Rockwall, Texas 75032 Phone: (469) 698-1000 |